Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Animal venoms are used as defense mechanisms or to immobilize and digest prey. In fact, venoms are complex mixtures of enzymatic and non-enzymatic components with specific pathophysiological functions. Peptide toxins isolated from animal venoms target mainly ion channels, membrane receptors and components of the hemostatic system with high selectivity and affinity. The present review shows an up-to-date survey on the pharmacology of snake-venom bioactive components and evaluates their therapeutic perspectives against a wide range of pathophysiological conditions. Snake venoms have also been used as medical tools for thousands of years especially in tradition Chinese medicine. Consequently, snake venoms can be considered as mini-drug libraries in which each drug is pharmacologically active. However, less than 0.01% of these toxins have been identified and characterized. For instance, Captopril® (Enalapril), Integrilin® (Eptifibatide) and Aggrastat® (Tirofiban) are drugs based on snake venoms, which have been approved by the FDA. In addition to these approved drugs, many other snake venom components are now involved in preclinical or clinical trials for a variety of therapeutic applications. These examples show that snake venoms can be a valuable source of new principle components in drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In vitro assessment of cytotoxic activities of Lachesis muta muta snake venom
Stransky, S., Costal-Oliveira, F., Lopes-de-Souza, L., Guerra-Duarte, C., Chávez-Olórtegui, C., & Braga, V. M. M. (2018) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006427 · Cited by 29
Cited by
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Snake Antivenoms—Toward Better Understanding of the Administration Route
Gamulin, E., Mateljak Lukačević, S., Halassy, B., & Kurtović, T. (2023) · Toxins · doi:10.3390/toxins15060398 · Cited by 30
Biomimetics provides lessons from nature for contemporary ways to improve human health
Stenvinkel, P., Avesani, C. M., Gordon, L. J., Schalling, M., & Shiels, P. G. (2021) · Journal of Clinical and Translational Science · doi:10.1017/cts.2021.790 · Cited by 11
“01% of the planet’s snake venom has so far been identified and characterised [123], the forests of our planet are full of potentially novel drugs.”
Boda, F., Banfai, K., Garai, K., Kovacs, B., Almasi, A., Scheffer, D., Sinkler, R. L., Csonka, R., Czompoly, T., & Kvell, K. (2020) · Journal of Venomous Animals and Toxins including Tropical Diseases · doi:10.1590/1678-9199-jvatitd-2020-0057 · Cited by 2
Metadata
- Authors
- Mohamed Abd El-Aziz, T., Soares, A. G., & Stockand, J. D.
- Venue
- Toxins
- Publisher
- MDPI AG
- Published
- 2019-09-25
- Volume
- 11
- Issue
- 10
- Pages
- 564
- ISSN
- 2072-6651 (ISSN-L)
- OpenAlex
- W2976778560
- Cited by
- 241
- References
- 1
- FWCI
- 13.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving. https://app.cochat.ai/papers/10.3390/toxins11100564
- The paper
- Mohamed Abd El-Aziz, T., Soares, A. G., & Stockand, J. D. (2019). Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving. Toxins. https://doi.org/10.3390/toxins11100564
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.